measles, mumps, rubella and varicella
Vaccines · 2007–2012
3decisions
3medicines
0carried consumer input
0individual submissions
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| measles, mumps, rubella and varicella virus vaccine live Immunisation of children aged 18 months against measles, mumps, rubella and varicella virus infection, as part of the National Immunisation Program. | Nov 2012 | Recommended | no section in document |
| The combination measles, mumps, rubella and varicella vaccine for children aged 12 months on the NIP. | Nov 2007 | Recommended with restriction | no section in document |
| measles, mumps, rubella and varicella vaccine Active immunization against measles, mumps, rubella and varicella in children aged 12 months. | Nov 2007 | Recommended with restriction | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.